Results 201 to 210 of about 56,264 (258)

Efficacy of NEPA for prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly emetogenic chemotherapy and usefulness of adding olanzapine for grade 2 or higher emesis. [PDF]

Medicine (Baltimore)
Na J, Kim JJ, Oh SB, Park K.
europepmc   +1 more source

Fact-finding and risk factor analysis of chemotherapy-induced nausea and vomiting in children with solid tumors: a prospective observational study. [PDF]

BMC Pediatr
Shao M, Li Y, Qin J, Zhou Y, Sun Y, Yang P, Wang X, Huang C, Su Y, Zhao W.   +9 more
europepmc   +1 more source

Improving Control of Chemotherapy-Induced Nausea and Vomiting

Cancer Control, 2012
openaire   +2 more sources

Serotonin Levels and Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Cross-Sectional Study. [PDF]

Asian Pac J Cancer Prev
Santosa D, Fitrikasari A, Iswaningtyas F, Kuntardjo N, Tandarto K, Hadiati T, Sumekar TA, Sarjana W, Wardani ND, Jusup I.   +9 more
europepmc   +1 more source

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting. [PDF]

BMC Cancer
Sun L, Ma J, Zhou Y, Ying X, Liang G, Pi G, Li Y, Luo Y, Bi J, He H, Peng Y.   +10 more
europepmc   +1 more source

Personalized Prophylactic Antiemetic Regimens for Control of Chemotherapy-Induced Nausea and Vomiting by Pharmacogenetic Analysis of Three Receptor Genes: HTR3A, HTR3B, TACR1. [PDF]

JCO Precis Oncol
Yeo W, Mo FKF, Huang J, Yeo HL, Ko WH, Li LV, Lau TKH, Lai KT, Pang E, Ou M, Ma SL, Tang NLS.   +11 more
europepmc   +1 more source

Olanzapine for Chemotherapy-induced Nausea and Vomiting Pediatric Population: Take Home Message? [PDF]

J Pediatr Hematol Oncol
Singh A, Gupta D.
europepmc   +1 more source

Acupressure On Chemotherapy-Induced Nausea and Vomiting among Breast Cancer Patients: A Systematic Review and Meta-analysis. [PDF]

Asian Pac J Cancer Prev
Issac A, Nayak SG, Halemani K, Mishra P, Chand G.   +4 more
europepmc   +1 more source

Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting. [PDF]

BMC Cancer
He L, Wang J, Pu W, Li H, Liu B, Wang Z, Han Q, Wang Y, Xu B, Hu J, Sun G, Chen H.   +11 more
europepmc   +1 more source

Correction to: Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials. [PDF]

Oncologist
europepmc   +1 more source